The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio

Shuai Deng1, Yijian Qiu1, Qiang Wang2

  • 1Chengdu Sport University School of Sports Medicine and Health, Chengdu, China.

PubMed

Insights

The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is linked to lower rheumatoid arthritis (RA) risk in older US adults. Further research is needed to confirm this association.

Area of Science:

  • Cardiovascular Health
  • Rheumatology
  • Lipid Metabolism

Background:

  • Rheumatoid arthritis (RA) may be linked to lipid metabolism.
  • The non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol (HDL-C) ratio (NHHR) is a novel index for atherosclerotic lipids.

Purpose of the Study:

  • To investigate the association between NHHR and RA incidence in the elderly US population.
  • To explore potential mediating roles of BMI and statin use in the RA-NHHR relationship.

Main Methods:

  • Analysis of NHANES data (2005-2018) from 6,433 elderly participants.
  • Multivariate logistic regression, subgroup, and restricted cubic spline (RCS) analyses were employed.
  • Mediation analysis was used to assess the role of BMI and statins.

Main Results:

  • A higher NHHR was associated with an 11% reduced risk of RA (OR: 0.87; 95% CI: 0.81-0.92).
  • Subgroup analyses indicated no significant interaction effects for age, gender, race, smoking, drinking, statins, or diabetes.
  • Mediation analysis identified a significant indirect effect of NHHR on RA through statin use (p < 0.01), and RCS analysis revealed a non-linear association (p < 0.05).

Conclusions:

  • NHHR levels are associated with a decreased incidence of rheumatoid arthritis in elderly US adults.
  • The non-linear relationship between RA and NHHR warrants further investigation, potentially through prospective cohort studies.
Abstract

Related Concept Videos

Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
272
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
259
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
361
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
70
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
52